Compare GILT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | INSP |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1997 | 2018 |
| Metric | GILT | INSP |
|---|---|---|
| Price | $15.24 | $42.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $19.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 943.4K | 934.7K |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $15.06 | $8.02 |
| Revenue Next Year | $11.72 | $8.11 |
| P/E Ratio | $42.82 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $6.20 | $38.91 |
| 52 Week High | $20.99 | $147.03 |
| Indicator | GILT | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 41.74 |
| Support Level | $13.38 | $39.26 |
| Resistance Level | $18.18 | $44.98 |
| Average True Range (ATR) | 1.07 | 1.89 |
| MACD | -0.11 | 0.51 |
| Stochastic Oscillator | 37.17 | 61.97 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.